• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin

    Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin

  2. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  3. Express Scripts : One of the Widest Moats in Health Care

    Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.

  4. Should You Buy Into This Buyback ETF?

    This distinctive strategy has a strong record, but its high turnover, fee, and myopic selection criterion detract from its appeal.

  5. The Buyback ETF

    This distinctive strategy has a strong record, but its high turnover, fee, and myopic selection criterion detract from its appeal.

  6. Express Scripts Well Positioned for New Health-Care Order

    The wide-moat pharmacy benefit manager is still undervalued.

  7. Market Overreaction Makes Express Scripts Even More Attractive

    Misunderstanding on private health insurance exchanges could mean opportunity for investors.

  8. Berkshire Likes Express Scripts --and So Do We

    The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.

  9. Will the Election Affect Earnings?

    If Americans sweep Democrats into office, these healthcare proposals could get a shot in the arm. Here’s how they would have an impact on earnings.

12345

©2017 Morningstar Advisor. All right reserved.